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1Testing the Efficacy of an Online Self-Help Treatment for Comorbid Alcohol Misuse and
Emotional Problems in Young Adults: A Randomized Controlled Trial (RCT)
Abstract
Background: Alcohol misuse and emotional problems (i.e., depression and anxiety) are highly 
comorbid among Canadian young adults. However, there is a lack of integrated, accessible, and 
evidence-based treatment options for these young adults.  
Objective: The main goal of this study is to develop and test the efficacy of an integrated, online
self-help program designed to target both alcohol misuse and emotional problems.
Methods: A two-arm randomized controlled trial (RCT) design will be used to compare the 
efficacy of the online integrated treatment to a psychoeducational control group. A target sample 
of 214 participants will be recruited and randomly assigned to either condition. The integrated 
treatment will last 8-weeks and participants will work through 12 modules. Modules will 
incorporate content based on principles of Cognitive Behavioural Therapy (CBT) and 
Motivational Interviewing (MI). Participants in the control group will receive links to 
psychoeducational resources and will have access to the full treatment after follow-up. The 
primary outcome will be the number of Canadian standard drinks consumed in the week leading 
up the assessment. Secondary outcomes of interest include symptoms of depression, anxiety, 
alcohol-related problems, quality of life, and use of other drugs. Assessments will be completed 
at three time points: at baseline, at the end of treatment (i.e., 8-weeks), and at follow-up (i.e., 24-
weeks). Upon completion, data will be analyzed using Generalized Linear Mixed Models 
(GLMM). 
Results: Data collection will begin in June 2018 and will continue until January 2020. Final 
study results will be submitted for publication by July 2020. 
Conclusions: Currently, there are no integrated treatments designed to target alcohol misuse and 
the range of emotional problems experienced in young adults. This research stands to provide an 
effective, accessible (i.e., online), and feasible option to treat the many struggling young adults in
this country. 
Trial Registration: Clinicaltrials.gov ID – NCT03406039
Keywords: alcohol misuse; depression; anxiety; cognitive behavioural therapy; motivational 
interviewing; integrated treatment; online; self-help
2Introduction
Many young adult Canadians struggle with comorbid alcohol misuse and emotional 
problems (i.e., depression and anxiety). According to national statistics, 3.1 million Canadians 
consume enough alcohol to place themselves at risk of harm or injury [1]. Existing reports show 
that 50-60% of adults with an alcohol use disorder also meet clinical criteria for a depressive 
and/or anxiety disorder [2-5]. Prevalence rates of these mental health concerns vary based on 
geographic location, with highest rates of alcohol abuse and emotional problems being reported 
by people living in rural and Northern communities [1]. Data also show that the combinations of 
alcohol misuse and depression and/or anxiety are the most frequent mental health comorbidities 
in general populations [6,7]. We know that this comorbidity results in high disease burden – 
much more than each disorder separately [6,7]. At the individual level, comorbid alcohol misuse 
and depression and/or anxiety is linked with chronic poor health, increased suicidality, marital 
dysfunction, physical injury, and early mortality [2,8,9]. At a societal level, this comorbidity 
contributes to overburden on the health care system, high rates of absenteeism and 
unemployment, and increased legal problems [10]. There is currently a need for effective 
integrated treatments designed to treat alcohol misuse and co-occurring emotional problems. 
The current study will design and deliver an online self-help intervention for comorbid 
alcohol misuse and emotional problems in young adults (ages 18-35). This intervention will 
contain strategies drawn from Cognitive Behavioural Therapy (CBT) and Motivational 
Interviewing (MI) – both evidence-based psychotherapies for alcohol misuse and 
depression/anxiety [11,12]. A main strength is that this intervention will be integrated – meaning 
that it will target symptoms of both alcohol misuse and depression/anxiety within the same 
treatment. The online platform is also advantageous relative to face-to-face approaches. We will 
be able to better reach individuals in rural and Northern communities – where we know that 
some of the highest rates of alcohol misuse and emotional issues exist. These individuals often 
have difficulty accessing in person treatments due to community remoteness. Thus, they may be 
left to struggle with major mental health concerns and associated harms. Furthermore, young 
adults may feel less stigma associated with accessing support online. Thus, the proposed 
treatment has the potential to improve the health and well-being of young adult Canadians and 
their families.  
Current State of Knowledge 
Research on integrated treatment is relatively new. This is surprising, given that it has 
been long understood that alcohol misuse and comorbid emotional problems are associated with 
a complex clinical presentation [5,8]. Specifically, the presence of an emotional disorder (relative
to its absence) contributes to high rates of relapse, greater functional impairment, and poorer 
responses to treatment among individuals with significant alcohol problems [5]. Traditional 
approaches to treating comorbid alcohol misuse and depression/anxiety include sequential or 
parallel intervention [13,14]. During a sequential approach, clinicians treat the disorder viewed 
as “primary” first, followed by the treatment of the comorbid condition. Often times, this means 
that symptoms of emotional problems are not addressed in treatment until an individual achieves 
some notable period of abstinence from drinking. Thus, in the sequential model, treatment is 
provided for one disorder at a time – with the more acute disorder (i.e., alcohol misuse) taking 
first priority. The sequential model of intervention remains the most widely used approach to 
treating alcohol misuse–depression/anxiety comorbidities [14]. In contrast, the parallel model 
3involves treating alcohol misuse and emotional problems separately by two distinct professionals
and/or clinical teams [13,14]. A notable example of this approach would be a person seeing a 
family doctor for management of antidepressant medications, while working with a psychologist 
to reduce drinking. Therefore, in the parallel model, an individual receives support for alcohol 
misuse and depression/anxiety simultaneously, but from distinct professionals.  
Although still widely used, sequential and parallel approaches are limited as intervention 
models for comorbid disorders [14]. A sequential approach may be necessary in crisis situations, 
such as when a person needs hospitalization for alcohol-related seizures or for acute suicidality. 
However, in the absence of an emergency warranting the immediate stabilization of one disorder 
over the other, sequential treatment may impede the treatment of both disorders [13]. 
Specifically, sequential treatment does not consider the interconnectedness of alcohol misuse and
emotional problems. Moreover, in a parallel treatment model, there is often little communication 
between the professionals independently treating each disorder [14]. This is problematic because 
professionals often have different case conceptualizations and treatment recommendations. 
Hence, it is very common for a person to receive conflicting advice and feedback in a parallel 
treatment approach [14]. Furthermore, it is up to the patient to integrate distinct treatment 
approaches, which is likely difficult due to high rates of cognitive impairment among those with 
alcohol problems [14]. The limitations of a parallel approach may lead to adverse patient 
outcomes, such as frustration, continued mental health challenges, and in the most extreme case, 
discontinuation of treatment of both disorders. Overall, attesting to the above limitations, the 
literature shows that sequential and parallel approaches result in poor treatment outcomes in 
those struggling with alcohol misuse and co-morbid emotional problems [15-17]. 
Integrated psychological treatments are designed to target symptoms of comorbid 
disorders within the same intervention [14]. There is a growing interest in combining CBT and 
MI to treat alcohol misuse and comorbid emotional problems [6,18]. CBT is an evidence-based 
therapy where the goal is for patients to develop better coping skills for alcohol and 
mood/anxiety issues [11]. These skills become important when patients have to navigate 
challenging internal (e.g., negative thoughts) and external (e.g., stressors) triggers in their daily 
lives. Meta-analyses show that CBT leads to significant reductions in depression and anxiety 
symptoms, with effect sizes being moderate-to-large relative to other treatments [11,19]. Relapse 
rates for depression after CBT also tend to be half those of medication treatments [20]. CBT has 
also been shown to be effective in reducing substance and alcohol use, though effect sizes tend to
be smaller relative to effects found for depression and/or anxiety [21]. Moreover, MI is an 
evidence-based psychological intervention, often described as a patient-centered, collaborative 
approach to help elicit and strengthen motivation for change [22]. The emphasis in MI is to help 
patients resolve ambivalence about change, and hence, move in a positive direction that is 
consistent with personal values. Several meta-analyses support the use of MI as a front-line 
intervention for alcohol misuse, with typical effect sizes being in the moderate-to-large range 
relative to no treatment [23]. MI has also been used to treat depression and anxiety, though the 
evidence base is comparably smaller than for alcohol misuse [24,25]. 
 
Emerging work suggests that combined CBT and MI have synergistic, beneficial effects 
on both alcohol misuse and comorbid emotional problems within an integrated framework [6]. 
MI aims to improve patients’ motivation for changing problem behaviours. Motivational deficits 
are common in both alcohol misuse and emotional disorders, and the data show that low 
4motivation for change predicts poor treatment engagement and poor outcomes [22]. By 
increasing motivation for change using MI, clients may be more willing to engage the effortful 
activities of CBT (e.g., homework, behavioural activation) – which are essential for building 
better coping skills. Concurrent MI may also help to clarify patients’ core values in CBT by 
developing a discrepancy between current and desired behaviour. Thus, from a theoretical 
perspective, MI and CBT naturally complement each other in the treatment of comorbid alcohol 
and emotional problems. While this is a relatively new treatment approach, emerging data is 
promising. Much of the work has focused on testing the usefulness of CBT/MI for alcohol 
misuse and comorbid depression [6]. Comparatively, there has been much less focus on targeting
co-occurring anxiety symptoms in this literature. A recent meta-analysis of 12 RCTs showed that 
combined integrated CBT/MI (relative to control conditions) reduces alcohol misuse and 
depressive symptoms [6]. Effect sizes were comparable for subclinical (relative to clinically-
elevated) symptoms, suggesting that integrated CBT/MI may be beneficial in earlier stages of 
risk, as well. Combined CBT/MI also has the potential to alleviate co-occurring anxiety 
symptoms in those with alcohol misuse. However, the usefulness of integrated treatments for the 
alcohol misuse-anxiety comorbidity remains unexamined. 
Rationale and Objectives of the Proposed Study
Current integrated psychological treatments use a traditional face-to-face modality [6]. 
However, there are distinct advantages to an online delivery of integrated treatment among 
Canadian young adults. First, online interventions would be able to reach young adults from rural
and Northern communities. We know from most recent health statistics that the highest rates of 
alcohol misuse and emotional issues exist in these communities [1]. Second, young adults may 
be more willing to engage in a self-help online intervention (relative to in person). This is 
because an online modality may be associated with reduced shame and stigma – which are 
known, persistent barriers to seeking treatment among substance abusers [26]. Third, online 
treatments offer the potential for early intervention [27,28]. Self-guided online interventions may
be helpful during a period earlier in the risk pathway when young adults are experiencing 
moderate (but still subclinical) problems. This may serve to prevent an escalation to clinical 
disorders later in adulthood. Finally, online interventions could significantly reduce the burden 
on the mental health care system in Canada. More young people with alcohol misuse and co-
occurring emotional problems would be helped for much less cost relative to inpatient 
treatments. Data show that cost-effective, online interventions reduce alcohol misuse [29], 
depression [30], and anxiety [31] separately, with effect sizes being comparable to those of in 
person treatments. 
The goal of the proposed study will be to adapt, implement, and test an integrated, online 
treatment for alcohol misuse and comorbid emotional problems in young adult Canadians. The 
intervention will be adapted from a new online integrated treatment developed by collaborators 
Schaub and colleagues at the Swiss Research Institute for Public Health and Addiction [29] 
called Take Care of You. This intervention is in German and Dutch, and it is the first online 
integrated treatment for alcohol misuse and depression in young adults. Take Care of Me (i.e., the
current intervention) is an internet-based, self-help program designed to reduce symptoms of 
alcohol use and emotional problems (i.e., depression and anxiety). The treatment combines 
elements of CBT and MI, and is designed to target young adults at-risk for developing more 
severe alcohol misuse, depression, and anxiety should they not receive care. This intervention 
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symptoms as well. This is an important and novel expansion of the German/Dutch intervention, 
given the high co-occurrence of alcohol misuse and anxiety symptoms in clinical and general 
populations [7,8]. Depression and anxiety symptoms also tend to co-occur at high rates in young 
adults [6]. Accordingly, the proposed study will be a Randomized Controlled Trial (RCT) 
examining the efficacy of an online, self-help intervention for alcohol misuse and comorbid 
emotional problems relative to a psychoeducational control group. We have the following 
hypotheses: 
1. Participants in the integrated treatment condition will show larger reductions in weekly 
alcohol use (primary outcome) relative to participants in the psychoeducational control group 
over the 8-week Take Care of Me program. 
2. Participants in the integrated treatment condition will show larger reductions on measures of 
alcohol misuse, depression, anxiety, as well as increases in a measure of quality of life 
(secondary outcomes) over the 8-week Take Care of Me program. 
3. Symptom improvements during integrated treatment will be maintained at 6-month follow-up.
Methods
Study Design
A two-arm RCT will be used. Eligible participants will be randomized to either the online
integrated treatment condition or the psychoeducational control condition. Assessments will 
occur before randomization (T0; baseline), at 8-weeks (T1; treatment end), and at 24-weeks (T2; 
follow-up). The study will not be blinded. Participants will be made aware of which condition 
they have been assigned to as soon as they complete baseline measures and are deemed eligible. 
Blinding of researchers is not necessary as they will not be providing treatment to participants. 
Recruitment
Recruitment of study participants will begin in June 2018 and continue until January 
2020. Participants will be recruited through a number of means across the country (see Figure 4).
Our main recruitment objective is to recruit across Canada by using online advertisements (e.g., 
Google Ads, Kijiji, Craigslist), contacting student services at major Canadian universities, and 
through social media (e.g., Facebook). The goal is that utilizing online means will ensure that a 
large sample of Canadian young adults receive the link to the study website. Prominent addiction
community services in the province of Manitoba have also agreed to assist with recruitment, 
which will provide access to many individuals struggling with alcohol use problems. Study 
posters will also be put up at community organizations, hospitals, local university campuses, and 
popular drinking locations (e.g., bars, restaurants). Recruitment rates will be monitored on an 
ongoing basis (e.g., % completing screening relative to % meeting criteria to participate). With 
regard to our recruitment strategies, one potential drawback is that participants may come 
primarily from the same place (e.g., the same university), creating a homogenous sample. 
However, our plan is to utilize many different avenues, with the goal of creating as heterogenous 
a sample as possible. Similarly, it is possible that those recruited through social media may share 
characteristics that interact with their experience in the program. Utilizing multiple recruitment 
strategies simultaneously as well as examining potential moderators upon data analysis will help 
to mitigate this potential challenge. 
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There has been a shift to include heterogeneous samples in RCTs to improve the 
generalizability of findings to other samples [32]. Therefore, inclusion/exclusion criteria will be 
kept to a minimum. Our main participant demographic will be young adult Canadians with at 
least moderate alcohol misuse and emotional symptoms. Young adults will be targeted as the 
highest national rates of drinking are observed among individuals in this age group [33]. 
Furthermore, we know young adults are at an increased risk of both alcohol-related problems and
emotional challenges [6]. Inclusion criteria for participation will be: 1) individuals between 18 
and 35 years of age, 2) scoring >3 for women and >4 for men on a brief version of the Alcohol 
Use Disorders Identification Test (AUDIT-C) [33], 3) self-reporting at least moderate depression 
and/or anxiety symptoms indicated by a score >16 on the Center for Epidemiological Studies 
Depression Scale (CES-D)[34], and/or a score of  >10 on the Generalized Anxiety Disorder 
Scale (GAD-7)[35], 4) fluency in English, and 5) having weekly Internet access. Individuals will
be ineligible to participate if: 1) they self-report engaging in other psychological or 
pharmacological treatments for alcohol misuse and/or depression/anxiety, 2) report elevated 
suicidality, defined as scoring greater than “minimal risk” on the P4 Suicidality Screener [36], a 
widely used measure in RCTs as well as in primary care settings worldwide, and 3) report current
psychosis or mania. 
Informed Consent Procedure
Interested participants will be invited to contact the primary investigators for a link to the 
study website (see Figure 1). They will have seen this contact information from any of the 
recruitment materials that informed them about the study. This link will include all pertinent 
information about the study. It will also direct them to the page where they will be able to 
provide informed consent on the treatment website. Prior to consenting, participants will be told: 
the inclusion/exclusion criteria of the study; the potential risks/benefits of completing the 
intervention; safety arrangements during and after the study; and that participation is voluntary. 
They will also be told circumstances under which they should contact their family doctor or 
another professional from an emergency list that will be accessible at all times via the menu item 
“Help Me” on the intervention website. They will first be provided with detailed instructions on 
how to create a user account for the self-help program and be encouraged to contact the 
researchers should they have any trouble. Informed consent will be demonstrated by checking 
several boxes, stating that they have read and understood the terms of the research. After 
participants have provided informed consent, they will be able to register on the study website. 
They will need to create a username as well as verify their account via e-mail before they can 
access the website. All data will be encrypted and stored on a Canadian host server. No other 
personal information will be required in order to register. After informed consent has been 
obtained and their account has been verified, they will immediately be asked to complete the 
baseline assessment measures in order to determine eligibility. 
Randomization and Trial Flow
Eligible participants will be randomly assigned to either the treatment or control 
condition using a 1:1 ratio (see Figure 1). This will happen automatically on the study website.
Participants will immediately be provided with instructions on the study website once they have 
been assigned to either group. Participants assigned to the treatment condition will be told that 
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how to proceed. Individuals assigned to the control condition will be provided links to general 
psychoeducation websites about alcohol and mental illness but told that they will be given full 
access to the program in six months. Assessments will then take place at the end of treatment 
(i.e., T1, 8-weeks), and at follow-up (i.e., T2, 24-weeks, or 16-weeks after the end of treatment). 
Participants will also be asked to provide brief feedback (e.g., helpfulness, enjoyment) about 
their experience in the program at the follow-up assessment. Participants will be reminded about 
the assessments at each time point via e-mail. They will receive automatic reminders about the 
assessment every two days for one week until they have completed the assessment. Participants 
will be compensated with a $10 Amazon gift card for each assessment that they complete, for a 
total potential compensation of $30. Participants will be told about the compensation process 
during informed consent. 
Integrated Treatment (Active Condition). The website content is a further development 
of the Take Care of You intervention [27] designed for use in English, with added content specific
to symptoms of both depression and anxiety. The study website includes a dashboard with user 
information, a diary for participants to track their alcohol use and mood, 12 treatment modules, 
and a “Help Me” page of additional resources in various Canadian communities. Participants in 
the treatment condition will have access to 12 treatment modules (see Figure 2) and will have 8-
weeks to complete the modules. The average amount of text in each module is roughly the same. 
The content of all modules will be derived from CBT and MI principles (Table 1). For example, 
through module engagement, young adults will identify goals related to alcohol use and mood, 
learn strategies to cope with alcohol cravings, triggers, and social pressures, and learn how to 
prevent relapse. There will also be content to target anxiety and depression, focusing on 
strategies designed to help reduce negative thinking and worry, increase behavioural activation, 
and increase self-care (e.g., sleep hygiene). While participants can technically access all modules
at once, they will be encouraged to work through the modules in sequential order. More 
specifically, they will be encouraged to complete 1-2 modules per week over the course of the 8-
weeks. However, they will be able to return to modules more than once or move ahead to 
modules that may be more relevant in a given moment if they so choose. For example, a 
participant may jump ahead to the relaxation module if they are having strong anxiety symptoms 
in a given week. Participants will be encouraged to complete the modules as many times as 
needed, and their progress will be visible on a digital progress bar. Modules will keep the place 
of participants within a module should they exit the program but want to continue where they left
off upon their return. Participants will also be asked to track their alcohol use, and 
depression/anxiety symptoms each week. On the “dashboard” intervention page, participants will
be able to see a graph depicting treatment progress. The website will automatically adapt for use 
on smartphones and tablets.  
Table 1
Overview of Module Content 
8Module Number and Title Module Content
M1: Introduction  Introduction to intervention
 Motivational enhancement (i.e., identifying 
reasons for change, and pros and cons of 
drinking and not drinking)
 Self-monitoring alcohol use and mood 
M2: Strategies for Meeting Your Goals  Strategies to change drinking habits, including 
stimulus control (e.g., ridding home of cues)
 Resisting alcohol in specific situations (e.g., 
situations involving negative emotions)
 Practicing refusal skills in high risk situations
 Developing personal strategies to 
reduce/abstain from harmful alcohol use
M3: Say Yes!  Learning about the relationship between mood 
and behaviour
 Increasing behavioural activation (i.e., 
scheduling rewarding/pleasurable activities 
during the week)
 Tips for dealing with motivational and 
implementation problems
M4: Learning to “Say No” to Alcohol  Learning about the various ways to say no to 
alcohol.
 Ways to resist social pressures to drink
 Trying out a few role-plays to practice drinking
refusal skills
M5: Identifying Risky Situations  Identifying personal high-risk situations for 
drinking
 Learning about “seemingly unimportant 
decisions” that could lead to heavy drinking
M6: Linking Negative Emotions and
Drinking to Life Problems
 Relating issues with mood/alcohol to problems
 The difference between controllable and 
uncontrollable problems
 Formal problem solving (including problem 
identification, generating possible solutions, 
evaluating possible solutions, selecting a course
of action, and evaluating implementation of 
action plan)
M7: Coping with Craving  Psychoeducation about craving (e.g., different 
forms of craving [mental and physical])
9 Introduce self-monitoring of craving
 New ways to effectively cope with cravings 
(e.g., distraction, talking, experiencing the 
craving, and recalling the negative outcomes of
drinking)
M8: Dealing with Slips  Define a “slip” versus a full-blown relapse
 Introduce ways to cope with slip in mood 
and/or drinking
M9: Challenging Automatic Negative
Thoughts
 Discuss think the link between thoughts, 
feelings, behaviours, and bodily sensations
 Review common thinking errors (or cognitive 
distortions)
 Introduce balanced thinking
 Encourage participants to make links between 
negative thoughts and drinking
 Encourage participants to complete at least one 
thought record for a problem situation 
 Identity ways to “test” negative thoughts in real
life
M10: Meeting Your Needs  Discussing “Sleep Hygiene”
 Ruminating and worrying less
 Increasing and/or improving social network
M11: Relaxation Exercise  Key relaxation exercise to reduce anxiety (i.e., 
progressive muscle relaxation)
 Deep breathing
 Scheduling relaxation times during the week
M12: Preserve Your Success  Identify “early warning signs” for slip/relapse
 Create personalized relapse prevention plan
 Discuss ways to cope with relapse
 Identify top five coping strategies
Intervention Support Person. The literature shows that adherence to treatment tends to be 
suboptimal in addiction intervention studies, including both in-person and online modalities [37].
In the present study, comorbid emotional symptoms may compound potential issues with 
treatment adherence. For example, depression is associated with low motivation, and this in turn,
may contribute to difficulties with treatment engagement and homework completion. The 
support-accountability module [38] posits that these difficulties with adherence, particularly in 
online programs, may be mitigated by the support of an individual who is viewed as competent, 
trustworthy, and available. Therefore, an intervention support person (i.e., a research assistant) 
will provide primarily automatic ongoing feedback about module progress, with reminders about
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completing sections of the intervention. This automatic feedback will also include motivational 
content that is personalized and signed off by the intervention support person. Please see Figure 
3 for examples of this automated motivational content for the first few weeks. E-mails of this 
nature will be sent for the duration of the active treatment condition. A research assistant 
involved in this component of the project will also provide support on demand – meaning that 
they will provide answers to questions when asked specifically by participants through e-mail. 
Therefore, the use of a research assistant for this purpose will help to reduce the risk of attrition. 
Consistent with previous research, automatic and personal feedback should also improve 
adherence, as is commonly observed in self-guided behaviour change interventions [38]. It is 
important to note that the purpose of the intervention support person (i.e., research assistant) in 
this role is not to take the place of a therapist, but rather to answer any questions participants 
may have as they work their way through the modules, which will be largely administrative. 
Despite the anticipated benefits of incorporating support of this nature, it is overall not 
considered equivalent to receiving in-person therapy. However, we will obtain data on the 
number of e-mails exchanged for participants in each condition. 
Dashboard. The purpose of this page is to provide a main menu where participants can 
access important information about the program and their progress in one place. On this page, 
they will be able to see the latest automated message from the Research Assistant, Deborah, the 
date in which they started the study, which assessments have been completed, their module 
progress, and their weekly mood and drinking diary. The dashboard will also have an activity 
portal where participants can log an activity and a corresponding mood if they wish.  
Social presence. In order to bring a small social presence to the treatment, each module 
will begin with a brief introduction video. Previous research suggests that adding this social 
factor will personalize the online program and may influence accountability [38], especially 
considering that it is self-guided. At the outset of treatment, participants will also be asked to 
select an animated personal companion whom they identify with in terms of sex, age, 
occupation, and family background. All companions will be fictional, yet relatable. The purpose 
of this companion is to provide advice and examples pertaining to the content throughout the 
intervention. The personal companion will appear in each module at least once. 
Consumption and mood diary. Participants in the integrated treatment condition will be 
asked to track both their weekly alcohol use and mood as they progress through the program. 
These levels will be displayed on a graph that will be visible to participants at all times. 
Participants will be able to observe simultaneous changes in alcohol use and negative mood by 
consistently filling out their diary. 
Psychoeducation (Control Condition). Consistent with similar RCTs conducted in the 
field [6,27], the control group will receive links to websites that provide general psychoeducation
about alcohol and mental illness. Therefore, the control group will be defined as having access to
available online psychoeducational material. Participants assigned to the control group will be 
told that they can cannot utilize the 12 modules right away, but that they can access said 
resources in the meantime if they wish, and that they will be provided access to the full 
intervention at the end of follow-up (i.e., 6-months after the first assessment). At both the end of 
treatment and at follow-up, participants assigned to the control condition will be asked which 
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resources they utilized and how many hours they spent, on average, looking at said resources. 
This will help support the notion that both knowledge acquisition and time were controlled for 
(i.e., differed between the two study arms).  
Measures
Table 2 provides a schedule of assessments. Demographic information will include age, 
biological sex, gender, ethnicity, history and treatment for any physical or mental conditions, and
family history of alcohol use. All self-report questionnaires will be administered online. 
Table 2
Schedule of Assessment Measures
Self-Report Measures Baseline (T0) 8 weeks (T1) 24 weeks (T2)
1. Demographics (e.g., age, sex, treatment 
history, psychiatric/medical history)
√
2. Suicidality (P4 Screener)
√
√ √
3. Timeline Follow Back (TLFB) √ √ √
4. Center for Epidemiological Studies Depression
Scale (CES-D)
√ √ √
5. Generalized Anxiety Disorder Scale (GAD-7) √ √ √
6. Alcohol Use Disorder Identification Test 
(AUDIT)
√ √ √
7. Quality of Life (WHOQL-BREF) √ √ √
8. Drug Use (NIDA ASSIST) √ √ √
9. Motivation Assessment √ √ √
Primary Outcome. Alcohol use will be assessed using the Timeline Follow-Back (TLFB)
procedure at all assessment points (T0-T2). The primary outcome measure will be the number of 
Canadian standard drinks consumed in the past seven days prior to the assessment. Standard 
drinks are defined as a 12oz can or bottle of beer, a 5oz glass of wine, or a 1.5oz shot of hard 
liquor. The TLFB has been shown to provide reliable and valid estimates of alcohol use and is 
widely used in basic [38] and treatment [27] studies.
Secondary Outcomes.
Depression. Depression symptoms will be captured at all assessment points (T0-T2) 
using the CES-D, a 20-item self-report questionnaire. A sum score will be used. The CES-D is 
one of the most widely used, validated measures of depression severity [34]. 
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Anxiety. Anxiety symptoms will be captured at all assessment points (T0-T2) using the 
GAD-7. The GAD-7 is a 7-item self-report instrument that measures severity of anxiety 
symptoms. A sum score will be used. Studies in the extant literature support its reliability and 
validity [37]. 
Alcohol Misuse. The AUDIT is a 10-item self-report measure designed to assess alcohol 
misuse and will be included in the current study as an additional secondary outcome. Overall, the
measure provides an indication of both alcohol use and alcohol-related problems. The AUDIT is 
a widely used, reliable, and valid estimate of alcohol misuse [33], and will be administered at all 
assessment points (i.e., T0, T1, and T2).
Combined Reduction of Alcohol Use and Comorbid Emotional Problems. We will also 
use a combined outcome to look at clinically significant reductions in alcohol misuse and 
depression or anxiety. Specifically, a short version of the AUDIT (first three items of the full 
AUDIT, referred to as AUDIT-C) will be used, where falling below 3 for women and 4 for men 
would reflect that participants are no longer drinking hazardously. Similarly, falling below 16 on 
the CES-D or 10 on the GAD-7 would reflect that participants are no longer experiencing 
moderate emotional symptoms. A binary outcome will be created for participants scoring below 
the AUDIT-C cut-off AND the cut-off for either depression or anxiety (coded as 1) versus those 
scoring above cut-offs (coded as 0). The AUDIT-C will also be used to determine eligibility 
during the baseline assessment. 
Quality of Life. An additional secondary outcome will be quality of life. The World 
Health Organization Quality of Life Assessment (WHOQOL-BREF) is a 26-item self-report 
measure that assesses functionality in various life domains (e.g., “How satisfied are you with 
your ability to perform your daily living activities?”). A sum score will be used to assess overall 
quality of life at all assessments (T0-T2). The WHOQOL-BREF has become one of the most 
widely used quality of life measures in the literature [39]. 
Drug Use. Participants' use of other drugs in addition to alcohol will also be included as a
secondary outcome and will be assessed using the National Institute on Drug Abuse Alcohol, 
Smoking, and Substance Involvement Screening Test (NIDA ASSIST) [40]. Examples of these 
additional substances include cannabis, cocaine, prescription medication, methamphetamine, and
opioids. This information will be collected to examine potential transfer effects to other 
substances.
Motivation. Finally, given the large MI component, participants’ level of motivation will 
be assessed at all assessment points. Motivation for change will be assessed along three 
dimensions: importance, confidence, and readiness. Participants will be asked how important it 
is, how confident they are, and how ready they are to change their alcohol use and negative 
emotions. Each item will be assessed using a single item on a scale ranging from 0 (Not 
Important/Confident/Ready) to 10 (Very Important/Confident/Ready). 
Sample Size Calculation
A recent meta-analysis showed that combined CBT and MI resulted in statistically 
significant reductions in alcohol use and depressive symptoms, with effect sizes being in the 
small range for both clinical and subclinical groups (g = .17-.27). Data show relatively 
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comparable effect sizes for online and in person interventions for alcohol misuse and emotional 
symptoms [29,30]. Therefore, a small effect size (g = .25) is expected for group differences in 
alcohol use and emotional symptoms at the end of treatment. Using G*Power, the sample size 
required to detect a small effect with 80% power, α = .05, and a correlation of .50 between 
repeated measures was N = 164. Based on previous literature using online interventions to target 
alcohol use and depression [28], approximately 30% of participants are expected to be lost at 
follow-up. Therefore, in order to take attrition into consideration, the sample size will be 
increased to N = 214. This will allow for a buffer should recruitment and attrition pose more of a 
challenge than anticipated.
Data Analysis Plan
Before hypothesis testing, we will run preliminary analyses (e.g., baseline differences, 
missing data analyses). We will also examine overall group differences in clinically meaningful 
variables (i.e., % below moderate cut-offs on the AUDIT, CES-D, and GAD-7 after treatment 
and at follow-up). Next, Generalized Linear Mixed Models (GLMM) will be used under the 
framework of intent-to-treat to evaluate the main hypotheses that integrated treatment will result 
in the largest reductions in alcohol use, depression, and anxiety. GLMM is a multilevel modeling
technique that is preferable to repeated-measures ANOVA for pre/post analyses, as it will allow 
us to include all randomized participants in analyses [41]. This results in less bias due to missing 
follow-up data [41]. However, due to potential attrition problems, we also plan to conduct a 
sensitivity analysis in order to ensure that data is missing at random. Primary and secondary 
outcomes will be tested sequentially in a mixed within- (repeated assessments) and between-
subjects (treatment condition) design. 
Safety
We are aware of the increased risks associated with recruiting young adults with 
moderate (and distressing) alcohol misuse and emotional symptoms. We would expect higher 
base rates of suicidality and self-harming behaviours in these individuals relative to those 
without these mental health concerns. Accordingly, we will have safeguards to minimize risk of 
harm. Young adults who report significant suicide ideation and/or plans during screening will be 
given a recommendation to visit their local medical professional or hospital for support. They 
will also be given access to the integrated intervention, but their data will not be analyzed nor 
included in the RCT. We will also be monitoring changes in suicidality at each assessment and 
will direct participants to emergency services if needed. Participants will also have full time 
access to a list of mental health services, including community resources, hospitals, and 
helplines. Supports will also be accessible to participants at all times via the menu item “Help 
Me” on the intervention website. Finally, participants in the control condition will be given 
access to the active treatment after the final assessment (6-months). They will receive all 
elements of the integrated intervention. In order to maintain transparency, updates will be made 
on clinicaltrials.gov at each stage of the research process. Finally, the project has been funded by 
Research Manitoba, meaning that it has undergone a substantial peer-review process also 
considering safety aspects right from the beginning.   
Results
The intervention will be designed to adhere to the ethical principles of the Declaration of 
Helsinki and the CONSORT guidelines for internet-based interventions [42]. The study has been 
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granted procedural ethics from the Psychology/Sociology Research Ethics Board at the 
University of Manitoba, P2017:128 HS21125. All study procedures will be conducted in 
accordance with this ethics board at the granting institution, who will receive updates of the 
study status and will immediately be notified when the study is complete. Finally, the 
intervention is currently registered on clinicaltrials.gov for traceability (ID: NCT03406039). We 
will update the status of the intervention at each stage of the study process in accordance with 
website guidelines.
Primary trial findings will be published in open-access journals so that both the public 
and policy-makers in Canada can learn about and use the intervention. Anonymized study data 
will be available on request and interested participants will be provided with a summary of the 
results once the study is complete. Finally, dissemination will also include providing talks at 
various community locations, major hospitals and universities, and at public institutions (e.g., 
libraries) to ensure that results are as far-reaching as possible.  
Discussion
High rates of substance use and emotional issues in Canada demonstrate a clear need for 
additional and more accessible mental health services in the country. Many provinces also have 
significant rural spread, meaning that several communities are dispersed throughout the province
with little access to major city centres. This poses a substantial challenge for providing equal 
access to mental health care services. Furthermore, young people living in remote communities 
are at a significant disadvantage, as they seem to be struggling most with substance use and 
related problems, but have limited access to treatment facilities. Thus, the proposed study has the
potential to substantially improve the health and well-being of young adults living across the 
country. Given that we will be targeting young adults (i.e., those who are early in the risk 
pathway), our intervention may help individuals change their mental health trajectories. That is, 
an early evidence-based intervention may provide “at-risk” young adults effective coping 
strategies and therefore, prevent the escalation of problems in the future, thus resulting in fewer 
adults with alcohol use and emotional disorders. Furthermore, the intervention stands to provide 
a cost-effective method (relative to traditional in person treatments) of improving mental health 
care delivery to Canadians. Online interventions have the potential to save the government 
millions of dollars via the reduced burden on the health care system. 
Limitations and Mitigation Plan
Intervention studies show substantial variability in attrition rates, depending on treatment 
orientation and clinical severity [43,44]. Generally, drop-out rates are high in populations with 
alcohol and substance use disorders – ranging from 21-80% [43]. We are aware of this possible 
influence on attrition. However, regular contact with the intervention support person will likely 
provide personalized support that is not typical of online interventions. This may reduce drop-
out. We will also offer participants the possibility to receive a summary report at the end of the 
study of overall findings. This report will contain information about effects of the treatment, 
significant or not, based on aggregate level data. The combined use of the strategies above will 
help reduce attrition. An additional limitation of this study is the use of self-report measures in a 
web-based format, of which not all have been tested online. However, assessments of this nature 
remain widely used in clinical research and increasing reliability and validity evidence for these 
online tools is accumulating in clinical literature. 
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Conclusion
The proposed intervention is a potentially effective, cost-friendly means to enhance 
mental health care delivery to young adults in Canada. Currently, no such treatments exist for 
young adults in the country who struggle with addiction and comorbid emotional problems. 
Research wise, the proposed intervention is a novel expansion of the Swiss study. One major 
new feature will be the inclusion of content that specifically targets anxiety symptoms – which 
are currently missing from existing online integrated treatments. It is essential to provide young 
adults with the skills to cope with these emotional problems because both are known triggers for 
alcohol misuse and both often occur within the same individual. Therefore, by including new 
skills to target anxiety, we will enhance the therapeutic benefits of our intervention. Overall, the 
proposed intervention stands to have a substantial positive impact on the lives of young 
Canadians and on government expenditures related to mental health care.
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RecruitmentFigure 1. Randomization and trial flow chart. 
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Figure 2. Main menu of intervention modules. 
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AFTER 1 WEEK
Intervention Group
Subjec
t
First Week is Over
Text Hi [Participant]!
You survived the first week! Congratulations! We hope you have been feeling 
well in the last few days.
Tomorrow starts your second week. Please log in today and fill out your diaries 
on [study website]. Fill in how much you drank in the past few days and how 
much you plan to drink in the upcoming week. Also, please enter your mood 
ratings for the previous week. 
At this time, we would also like to encourage you to start another module if you 
haven’t yet done so. The more modules you do, the more likely you are to make 
progress!
Have a good week,
Deborah
AFTER 2 WEEKS
Intervention Group
Subjec
t
Two Weeks So Far
Text Hello [Participant]
Two weeks have passed. We hope you are doing well and are starting to become 
familiar with the layout of this treatment program. 
Tomorrow starts your third week. Please log in today and fill out your alcohol 
use and mood diaries on [study website] 
Fill in how much you drank in the past few days and how much you plan to 
drink for in upcoming week. Also, Also, please enter your mood ratings for the 
previous week. 
Have a good week,
Deborah
AFTER 3 WEEKS
Intervention Group
Subjec
t
Week Three
Text Hello [Participant]!
You’ve completed three weeks of this course now! You’re doing great. 
Maybe people in your life have noticed some changes in your behavior, (e.g. 
that you do not drink as much as you used to). If you encounter people trying to 
convince you to drink, we suggest you work through Module 4 (Say No).
And as always, don’t forget to update your drinking diary with your 
consumption for last week, as well as your intentions for next week on: [study 
website]. Also, please enter your mood ratings for the previous week. 
Have a good week,
Deborah
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Figure 3. Examples of automated motivational e-mails sent by the intervention support person 
(i.e., research assistant).
Figure 4. Wording to be used in 
recruitment e-mails and 
advertisements. 
Dear Participant,
You are receiving this e-mail 
because you may be eligible 
to participate in an online 
study being offered to young 
adults in Canada between the 
ages of 18 to 35 struggling 
with alcohol use and 
anxiety/depression?
The purpose of this study is 
to test the effectiveness of an 
8-week, self-directed online 
treatment program designed 
to help you cope with 
symptoms of alcohol use and 
anxiety/depression. Over the 
course of the 8-weeks, you 
will learn strategies and 
techniques from 12 different 
modules to help you cope 
with these challenges, while 
also receiving online support 
from our researchers. Our 
RESEARCH STUDY
Are you between the ages of
18-35 and currently
struggling with alcohol use
and anxiety/depression?
If so, you may benefit from 
joining our treatment study 
about alcohol misuse and 
emotional problems in young 
adult Canadians.
You will be invited to 
participate in an 8-week, self-
directed online treatment 
program designed to help you
cope with symptoms of 
alcohol use and 
anxiety/depression. The 
program consists of 12 
modules. 
While participating in the 
online program may be 
challenging at times, it may 
also help reduce your alcohol
use, as well as improve your 
emotional well-being. All of 
the information you provide 
during your participation in 
this study will remain 
confidential. You will also 
receive a small honorarium 
for your participation. 
*NOTE: You must not 
currently be in treatment 
elsewhere and be prepared to 
commit approximately 3 
hours/week.
If you have any questions 
about this research, or for 
more information, please 
contact: Dr. Matthew Keough
OR Jona Frohlich. Email: 
support@takecareofme.ca     
This research has been 
approved by the University of
Manitoba 
Psychology/Sociology 
Research Ethics Board. 
Concerns can be directed to 
the Human Ethics 
Coordinator @ 204-474-8113
or email: 
humanethics@umanitoba.ca
